Increased serum ADA activity has been shown to be involved in various metabolic and inflammatory diseases, including atherosclerosis (13), thrombosis (14), acute myocardial infarction (15), hypertension (16, 17), Graves’ disease (18), and T2D (19). Here, ADA is linked to deep vein thrombosis.